How many units of Cartalax should I draw?

It depends on your vial size, BAC water, and dose. For a 20mg vial with 0mL BAC water, a beginner dose of 10mg is typically 0 units on a U-100 syringe. Use the calculator above for your exact numbers.

How much BAC water should I add to Cartalax?

The standard amount is 0mL of bacteriostatic water for a 20mg vial. More water gives a more dilute solution — easier to measure small doses. Less water means fewer injections per vial. Adjust the BAC water slider in the calculator to see how it changes your syringe units.

How long does a Cartalax vial last?

At a beginner dose of 10mg daily, a 20mg vial lasts about 2000 doses. The calculator shows exact doses per vial for your selected tier.

What syringe should I use for Cartalax?

Most people use a U-100 insulin syringe (1mL / 100 units). For very small doses, a U-50 or U-30 syringe gives better precision. The calculator adjusts units automatically for whichever syringe you pick.

Cartalax Dosage Calculator

Healing & RecoveryOralResearch~15-30 minutes half-life

Cartalax is a synthetic tripeptide with the sequence Ala-Glu-Asp (AED), developed by Prof.

Increased chondrocyte proliferation observed in rat cartilage cultures (18-38% cartilage area index increase)Upregulation of PCNA and Ki-67 proliferation markers in preclinical modelsReduced p53 and caspase-3 activity, suggesting anti-apoptotic effects on cartilage cellsInhibition of MMP-9 synthesis, which may help preserve cartilage extracellular matrix4 weeks on / 8 weeks off

Vial Size

BAC Water (mL)

Dosing Level

10mcg · Daily

Custom Dose (mcg) — optional

Syringe Type

0.0 units

100 units (1mL)

Concentration

mcg/mL

Draw Volume

< 0.001

Syringe Units

< 0.1

units

Doses / Vial

doses

Summary: Add 0mL BAC water to your 20mg vial. Draw to < 0.1 units on a U-100 syringe for a 10mcg dose. This vial will last 0 doses.

Cycle Planner

Cycle Length (weeks)

Price Per Vial ($) — optional

Oral. Typical beginner frequency: daily.

Cartalax Pharmacokinetics

Pharmacokinetics — Active Dose Over Time

t½ = ~15-30 minutes (estimated from tripeptide class)

After 1 half-life (23m): 50% remainsAfter 2 half-lives (45m): 25% remainsAfter 3 half-lives (1h): 12.5% remains

At a 20mcg dose: 50% = 10mcg remaining after 23m. Recommended frequency: Daily.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.

Cartalax Dosing Protocol

Level	Dose / Injection	Frequency
Beginner	10mg	Daily
Moderate	20mg	Daily
Aggressive	20mg	2x Daily

Note: Synthetic tripeptide bioregulator (Ala-Glu-Asp) developed by Khavinson. Targets cartilage tissue and chondrocyte gene expression. Taken orally as capsules — no reconstitution required. Dosing is based on Russian bioregulator protocols; there are no Western clinical trials or formal PK studies.

About Cartalax

Cartalax is a synthetic tripeptide with the sequence Ala-Glu-Asp (AED), developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It's derived from sequences found in the alpha-1 chain of type XI collagen, a structural protein concentrated in cartilage tissue. In preclinical models, Cartalax has shown the ability to stimulate chondrocyte proliferation in cartilage tissue from both young and old rats. Studies report an 18-38% increase in cartilage area index, alongside upregulation of PCNA (a proliferation marker) and downregulation of p53 (a pro-apoptotic signal). The peptide also appears to inhibit MMP-9 synthesis, which could help preserve extracellular matrix integrity during aging. A 2023 study examined the AED peptide's effect on chondrogenic differentiation of human mesenchymal stem cells during replicative aging. At concentrations of 200 ng/mL, Cartalax activated genes and proteins associated with cartilage formation in aging stem cells, suggesting potential relevance to osteoarthritis research. All current evidence is preclinical, and Western research on this specific peptide remains very limited.

View full Cartalaxguide →Add to schedule →